AMA #45: Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent
This episode of The Drive podcast explores the pros and cons of GLP-1 weight loss drugs, including semaglutide and tirzepatide. It also examines the use of metformin as a potential geroprotective agent, reviewing data and Peter Attia's perspective on its efficacy.